同病类证的提出,对于如何发展中医辨病论治具有重要的意义。以往总是强调中医的特点是辨证论治,忽视了辨病论治,事实上张仲景的"方证相应"理论就蕴含"辨病论治"思想的萌芽。辨病论治是辨证论治在现代科技背景下的扩展和延伸,是扩大中医药影响,发展中医药事业的重要途径。复方丹参滴丸能在美国FDA顺利通过二期临床试验,其中重要的原因就在于将冠心病慢性心肌缺血作为适应症,与国际惯例和现代医学实行了接轨。我们需要在进一步发扬中医辨证论治的基础上,丰富中医辨病论治的实践,这些取决于我们能否突破常规,为这一创新思路营造一个良好的学术氛围。

Theory of "analogous syndrome complex in the same disease" is important in the development of disease differentiation and treatment of traditional Chinese medicine(TCM).Syndrome differentiation and treatment used to be considered as the characteristic of TCM.But disease differentiation and treatment,which was also included in the theory of "formula corresponds to the syndrome complex" by Dr.Zhang Zhongjing,was neglected.In modern technology environment,disease differentiation and treatment is the expansion and extension of syndrome differentiation and treatment.It is also an important way of promoting TCM development.Composite Denshen Pilulae(CDP) was successfully passed phase Ⅱ clinical trials of FDA in America.One of the important causes is that CDP took chronic myocardial ischemia of coronary heart disease as its indication,which met the international and modern medicine practice.Clinical practice calls for enrichment of disease differentiation and treatment on the basis of further development of TCM syndrome differentiation and treatment.A favorite atmosphere needs to be created for the innovation thought.

国家中医药管理局重点学科建设项目:2010中西医结合临床学科,负责人:张腾;上海市教委重点学科建设(第五期)(J50307):中西医结合临床,负责人:徐列明